Latest news Back to 'Institute of Cancer and Genomic Sciences' The Conversation: Autoimmune diseases: we discovered how to turn white blood cells from attacking the body to protecting it DescriptionProfessors David Wraith and Peter Cockerill write for The Conversation on their research that has shown that you can stop the immune system attacking the nerves.Date:15/06/2020 First drugs announced in major COVID-19 drugs trial DescriptionTwo UK drugs companies will be the first to partner with the Universities of Birmingham and Oxford as part of a major new UK drugs trial to test potential therapeutics to treat patients hospitalised with COVID-19.Date:10/06/2020 Birmingham scientists 're-train' immune system to prevent attack of healthy cells in new UK study into autoimmune diseases DescriptionThe body's immune system can be re-wired to prevent it from recognising its own proteins which, when attacked by the body, can cause autoimmune diseases like multiple sclerosis.Date:09/06/2020 Experts release new guidelines for studies into most effective treatments for HPV-positive throat cancer DescriptionHeightened caution is needed when considering de-escalation trials for patients with Human papillomavirus (HPV)-positive oropharyngeal cancer (OPC), to ensure minimal harm to patients.Date:05/06/2020 COVID-19 patients who undergo surgery are at increased risk of postoperative death – global study DescriptionPatients undergoing surgery after contracting coronavirus are at greatly increased risk of postoperative death, a new global study published in The Lancet reveals.Date:29/05/2020 COVID-19 mortality in cancer patients is not significantly affected by anti-cancer treatments, study finds DescriptionA new study led by the Universities of Birmingham and Oxford has found the mortality rate in cancer patients who are assessed or treated in hospital with COVID-19 is not significantly affected by anti-cancer treatments.Date:28/05/2020 University of Birmingham secures funding for critical UK clinical trial for children diagnosed with rare childhood cancer DescriptionA team will coordinate the UK arm of a critical European clinical trial which could lead to the development of more effective and kinder treatments for children diagnosed with a rare and aggressive childhood cancer.Date:21/05/2020 COVID-19 disruption will lead to 28 million surgeries cancelled worldwide DescriptionOver 28 million elective surgeries across the globe could be cancelled as a result of the COVID-19 pandemic – leading to patients facing a lengthy wait for their health issues to be resolved, a new study reveals.Date:15/05/2020 Three Birmingham Professors announced as Academy of Medical Sciences Fellows DescriptionThree professors from the University of Birmingham have been named among the UK's most prominent biomedical and health scientists by the Academy of Medical Sciences in its prestigious list of Fellows.Date:14/05/2020 Major COVID-19 drugs trial begins in Birmingham DescriptionA trial which will rapidly test new therapies for patients hospitalised due to COVID-19 is opening in Birmingham this week.Date:12/05/2020 Displaying 1 to 10 of 124 Previous 1 2 3 4 5 … Next